Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unmanipulated bone marrow (BM) transplantation from a related, haploidentical donor. All patients were prepared with an identical conditioning regimen including Thiotepa, Busilvex, Fludarabine (TBF) and antithymocyte globulin given at myeloablative (MAC = 68) or reduced (reduced intensity conditioning (RIC) = 29) dose intensity and received the same GvHD prophylaxis consisting of the combination of methotrexate, cyclosporine, mycofenolate-mofetil and basiliximab. Patients were transplanted in 1st or 2nd CR (early phase: n = 60) or in > 2nd CR or active disease (advanced phase: n = 37). With a median time of 21 days (range 12-38 days), the cumul...
We report 634 patients who underwent unmanipulated haploidentical (HAPLO) bone marrow transplantatio...
This is an update on acute and chronic graft-versus-host disease (GvHD) in 425 patients with hematol...
AbstractFifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploiden...
Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unman...
Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unman...
Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unman...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
In this study we investigated the feasibility and clinical value of non T-cell depleted bone marrow ...
In this study we investigated the feasibility and clinical value of non T-cell depleted bone marrow ...
This is a report of 148 patients with hematologic malignancies who received an unmanipulated haploid...
AbstractFifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploiden...
AbstractFifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploiden...
We report 634 patients who underwent unmanipulated haploidentical (HAPLO) bone marrow transplantatio...
This is an update on acute and chronic graft-versus-host disease (GvHD) in 425 patients with hematol...
AbstractFifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploiden...
Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unman...
Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unman...
Ninety-seven patients affected by high-risk hematological malignancies underwent G-CSF primed, unman...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–primed BM tra...
In this study we investigated the feasibility and clinical value of non T-cell depleted bone marrow ...
In this study we investigated the feasibility and clinical value of non T-cell depleted bone marrow ...
This is a report of 148 patients with hematologic malignancies who received an unmanipulated haploid...
AbstractFifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploiden...
AbstractFifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploiden...
We report 634 patients who underwent unmanipulated haploidentical (HAPLO) bone marrow transplantatio...
This is an update on acute and chronic graft-versus-host disease (GvHD) in 425 patients with hematol...
AbstractFifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploiden...